Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression
Clinical trial NCT06975332 · RECRUITING
Trial details
- NCT number
- NCT06975332
- Sponsor
- Medical University of Warsaw
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-09
- Primary completion
- 2026-09-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.